Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan

Pain

Volumn 101, Issue 1-2, 2003, Pages 175-186

  Wacnik, Paul W ^a   Kehl, Lois J ^b   Trempe, Thomas M ^b   Ramnaraine, Margaret L ^a   Beitz, Alvin J ^a,c   Wilcox, George L ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer pain; Fibrosarcoma; Forelimb; Morphine; Movement related hyperalgesia; Musculoskeletal pain

Indexed keywords

CARRAGEENAN; MORPHINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DESTRUCTION; BONE METASTASIS; CANCER TRANSPLANTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG POTENCY; FOREFOOT; FORELIMB; GRIP STRENGTH; HISTOLOGY; HUMERUS; HYPERALGESIA; LIMB MOVEMENT; MALE; MELANOMA CELL; MOUSE; MYOSITIS; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; TRICEPS BRACHII MUSCLE;

EID: 0037221710     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(02)00312-3     Document Type: Article

References (39)

1. Banning A., Sjogren P., Henriksen H. Treatment outcome in a multidisciplinary cancer pain clinic [see comments]. Pain. 47:1991;129-134. (discussion 127-128).
2. Bennett A.D., Chastain K.M., Hulsebosch C.E. Alleviation of mechanical and thermal allodynia by CGRP(8-37) in a rodent model of chronic central pain. Pain. 86:2000;163-175.
3. Bruera E., Schoeller T., Wenk R., MacEachern T., Marcelino S., Hanson J., Suarez-Almazor M. A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage. 10:1995;348-355.
4. Cabot P.J., Carter L., Gaiddon C., Zhang Q., Schafer M., Loeffler J.P., Stein C. Immune cell-derived beta-endorphin. Production, release, and control of inflammatory pain in rats. J Clin Invest. 100:1997;142-148.
5. Cain D.M., Wacnik P.W., Turner M., Wendelschafer-Crabb G., Kennedy W.R., Wilcox G.L., Simone D.A. Functional interactions between tumor and peripheral nerve: changes in excitability and morphology of primary afferent fibers in a murine model of cancer pain. J Neurosci. 21:2001;9367-9376.
6. Clohisy D.R., Ogilvie C.M., Carpenter R.J., Ramnaraine M.L. Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts. J Orthopaed Res. 14:1996;2-6.
7. Daeninck P.J., Bruera E. Opioid use in cancer pain. Is a more liberal approach enhancing toxicity? Acta Anaesthesiol Scand. 43:1999;924-938.
8. Elmer G.I., Pieper J.O., Negus S.S., Woods J.H. Genetic variance in nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests. Pain. 75:1998;129-140.
9. Fairbanks C.A., Schreiber K.L., Brewer K.L., Yu C.G., Stone L.S., Kitto K.F., Nguyen H.O., Grocholski B.M., Shoeman D.W., Kehl L.J., Regunathan S., Reis D.J., Yezierski R.P., Wilcox G.L. Agmatine reverses pain induced by inflammation, neuropathy, and spinal cord injury. Proc Natl Acad Sci USA. 97:2000;10584-10589.
10. Hains B.C., Chastain K.M., Everhart A.W., McAdoo D.J., Hulsebosch C.E. Transplants of adrenal medullary chromaffin cells reduce forelimb and hind limb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury. Exp Neurol. 164:2000;426-437.
11. Hamamoto D.T., Croft D.L., Norsted B.D., Wacnik P.W., Kehl L.J., Wilcox G.L., Simone D.A. The cannabinoid receptor agonist WIN 55,212-2 attenuates tumor-evoked hyperalgesia in a murine model of cancer paijn. Soc. for Neurosci. Abstr. 716.5:2001.
12. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience. 98:2000;585-598.
13. Honore P., Luger N.M., Sabino M.A., Schwei M.J., Rogers S.D., Mach D.B., O'Keefe P.F., Ramnaraine M.L., Clohisy D.R., Mantyh P.W. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord [published erratum appears in Nat Med 2000 Jul;6(7):838]. Nat Med. 6:2000;521-528.
14. Jacob J., Michaud G., Nicola M.A., Prudhomme N. Genetic differences in opioids binding sites and in antinociceptive activities of morphine and ethylketocyclazocine. Life Sci. 33:1983;645-648.
15. Kehl L.J., Trempe T.M., Hargreaves K.M. A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain. 85:2000;333-343.
16. Kehl L.J., Norsted B.D., Croft D.L., Wacnik P.W., Hamamoto D.T., Wilcox G.L., Simone D.A. The cannabinoid receptor agonist WIN 55,212-2 attenuates carrageenan-evoked muscle hyperalgesia. Soc. for Neurosci. Abstr. 716.6:2001.
17. Kuraishi Y. Effects of morphine on cancer pain and tumor growth and metastasis. Nippon Rinsho-Jpn J Clin Med. 59:2001;1669-1674.
18. Medhurst S.J., Walker K., Bowes M., Kidd B.L., Glatt M., Muller M., Hattenberger M., Vaxelaire J., O'Reilly T., Wotherspoon G., Winter J., Green J., Urban L. A rat model of bone cancer pain. Pain. 96:2002;129-140.
19. Mense S., Light A.R., Perl E.R. Spinal terminations of subcutaneous high-threshold mechanoreceptors. Rethelyi A.G.B.a.M. Spinal Cord Sensation. 1981;79-86 Scottish Academic Press, Edinburgh.
20. Luger N.M., Honore P., Sabino M.A., Schwei M.J., Rogers S.D., Mach D.B., Clohisy D.R., Mantyh P.W. Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res. 61:2001;4038-4047.
21. Mercadante S. Malignant bone pain: pathophysiology and treatment. Pain. 69:1997;1-18.
22. Mercadante S., Portenoy R.K. Opioid poorly-responsive cancer pain. Part 1: Clinical considerations. J Pain Symptom Manage. 21:2001;144-150.
23. Mercadante S., Portenoy R.K. Opioid poorly-responsive cancer pain. Part 2: Basic mechanisms that could shift dose response for analgesia. J Pain Symptom Manage. 21:2001;255-264.
24. Mercadante S., Maddaloni S., Roccella S., Salvaggio L. Predictive factors in advanced cancer pain treated only by analgesics. Pain. 50:1992;151-155.
25. Plunkett T.A., Rubens R.D. The biology and management of bone metastases. Crit Rev Oncol-Hematol. 31:1999;89-96.
26. Portenoy R.K. Chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage. 5:1990;S46-S62.
27. Portenoy R.K. Current pharmacotherapy of chronic pain. J Pain Symptom Manage. 19:2000;S16-S20.
28. Portenoy R.K., Lesage P. Management of cancer pain. Lancet. 353:1999;1695-1700.
29. Portenoy R.K., Payne D., Jacobsen P. Breakthrough pain: characteristics and impact in patients with cancer pain. Pain. 81:1999;129-134.
30. Rubens R.D. Bone metastases - The clinical problem. Eur J Cancer. 34:1998;210-213.
31. Schwei M.J., Honore P., Rogers S.D., Salak-Johnson J.L., Finke M.P., Ramnaraine M.L., Clohisy D.R., Mantyh P.W. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci. 19:1999;10886-10897.
32. Sluka K.A. Development and time course of secondary heat and mechanical hyperalgesia following capsaicin or carrageenan injection of muscle, joint or skin. Soc Neurosci Abstr. 26:2000;2192.
33. Sluka K.A., Kalra A., Moore S.A. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve. 24:2001;37-46.
34. Stackpole C.W., Alterman A.L., Fornabaio D.M. Growth characteristics of clonal cell populations constituting a B16 melanoma metastasis model system. Invasion & Metastasis. 5:1985;125-143.
35. Tallarida R., Murray R. Manual of Pharmacological Calculations with Computer Programs. 2nd Ed. 1987;Springer, New York, NY. pp. 26-31.
36. Wacnik P.W., Wilcox G.L., Clohisy D.R., Ramnaraine M.R., Eikmeier L.J., Beitz A.J. Devor M., Rowbotham M.C., Wiesenfeld-Hallin Z. Cancer pain mechanisms and animal models of cancer pain. Proceedings of the 9th World Congress on Pain. 2000;615-637 IASP Press, Seattle, WA.
37. Wacnik P.W., Eikmeier L.J., Ruggles T.R., Ramnaraine M.L., Walcheck B.K., Beitz A.J., Wilcox G.L. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci. 21:2001;9355-9366.
38. Yoneda T. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone. Eur J Cancer. 34:1998;240-245.
39. Zhou L., Zhang Q., Stein C., Schafer M. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J Pharmacol Exp Ther. 286:1998;1000-1006.